<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Good manufacturing practices for pharmaceuticals</title>
  </titleInfo>
  <name type="personal">
    <namePart>Nally, Joseph D.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nyu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York, NY</placeTerm>
    </place>
    <publisher>Informa Healthcare</publisher>
    <dateIssued>c2007</dateIssued>
    <dateIssued encoding="marc">2007</dateIssued>
    <edition>6th ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>viii, 398 p. : ill. ; 26 cm.</extent>
  </physicalDescription>
  <tableOfContents>Preface / Joseph D. Nally -- Contributors -- 1. Status and Applicability of U.S. Regulations: Current Good Manufacturing Practices in Manufacturing, Processing, Packaging, and Holding of Drugs / Joseph D. Nally -- 2. Finished Pharmaceuticals: General Provisions, Subpart A / Joseph D. Nally -- 3. Organization and Personnel, Subpart B / Joanne W. Cochran and Joseph D. Nally -- 4. Buildings and Facilities, Subpart C / Robert Del Ciello -- 5. Equipment, Subpart D / Robert Del Ciello, Joseph T. Busfield, and Steven Ostrove -- 6. Control of Components and Drug Product Containers and Closures , Subpart E / Arlyn R. Sibille -- 7. Production and Process Controls, Subpart F / Joseph D. Nally and Michael D. Karaim -- 8. Packaging and Labeling Control, Subpart G / Arlyn R. Sibille -- 9. Holding Distribution, Subpart H / Joseph D. Nally -- 10. Laboratory Controls, Subpart I / Wayne J. DeWitte and Lex M. Hoinowski -- 11. Records and Reports, Subpart J / Arlyn R. Sibille, Steven Ostrove, Joseph D. Nally, and Laura L. Nally -- 12. Returned and Salvaged Drug Products, Subpart K / Joseph D. Nally -- 13. Repacking and Relabeling / Joseph D. Nally -- 14. Quality Systems and Risk Management Approaches / Joseph D. Nally and Laura L. Nally -- 15. Clinical Trial Supplies and Current Good Manufacturing / Graham Bunn -- 16. Contracting and Outsourcing / Graham Bunn -- 17. Active Pharmaceutical Ingredients / P. Denis Celentano -- 18. Bulk Pharmaceutical Excipient GMPs / Irwin Silverstein -- 19. Recalls, Warning Letters, Seizures and Injunctions: CGMP Enforcement Alternatives in the United States / Joseph D. Nally -- 20. Control Substances Safeguards (21 CFR 1300, et seq.) / Joseph D. Nally -- 21. The Inspection Procedures for Compliance in the United States: The Regulatee is Inspected; The Rational for Inspection (21 USC 373, 374) / Joseph D. Nally -- 22. FDA Pre-Approval Inspections/Investigations: The Road from Scale-Up and Post-Approval Changes in the Food and Drug Modernization Act / Joseph D. Nally -- 23. World-Wide Good Manufacturings Practices / Joseph D. Nally -- 24. Quality Approaches: ISO 9000, Malcolm Baldrige, and Six Sigma / Joseph D. Nally -- Appendix A: Center for Drug Evaluation and Research: List of Guidance Documents -- Appendix B: ICH Guidelines -- Appendix C: Food and Drug Administration (FDA) Office Regulatory Affairs (ORA) Compliance Policy Guides -- Index.</tableOfContents>
  <note type="statement of responsibility">edited by Joseph D. Nally.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Pharmaceutical industry</topic>
    <topic>Quality control</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Standards</topic>
    <geographic>United States</geographic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmaceutical Preparations</topic>
    <topic>standard</topic>
  </subject>
  <subject authority="mesh">
    <topic>Drug Industry</topic>
    <topic>standard</topic>
  </subject>
  <subject authority="mesh">
    <topic>Legislation, Drug</topic>
  </subject>
  <subject authority="mesh">
    <topic>Quality Control</topic>
  </subject>
  <subject authority="mesh">
    <topic>Technology, Pharmaceutical</topic>
    <topic>standard</topic>
  </subject>
  <subject authority="mesh">
    <geographic>United States</geographic>
  </subject>
  <classification authority="lcc">RS189 .W57 2007</classification>
  <classification authority="ddc" edition="22">615.19 GOO</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>Drugs and the pharmaceutical sciences, v. 169</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">0849339723</identifier>
  <identifier type="isbn">9780849339721</identifier>
  <identifier type="lccn">2007272501</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/toc/fy0709/2007272501.html</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/enhancements/fy0713/2007272501-d.html</identifier>
  <location>
    <url displayLabel="Table of contents only">http://www.loc.gov/catdir/toc/fy0709/2007272501.html</url>
  </location>
  <location>
    <url displayLabel="Publisher description">http://www.loc.gov/catdir/enhancements/fy0713/2007272501-d.html</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">UNM</recordContentSource>
    <recordCreationDate encoding="marc">070323</recordCreationDate>
    <recordChangeDate encoding="iso8601">20150121174605.0</recordChangeDate>
    <recordIdentifier source="BD-DhUL">14781242</recordIdentifier>
  </recordInfo>
</mods>
